Research Reports | Market Assessment
June 2020

Chimeric Antigen Receptor (CAR) T-Cell Therapy – Clinical Trials – Oncology Clinical Trial Monitor

Table of contents

  • Chimeric Antigen Receptor (CAR) T-Cell Therapy - Clinical Trials - Oncology Clinical Trial Monitor
Anamika Ghosh, Ph.D.
Anamika Ghosh, Ph.D.

Anamika Ghosh, M.Sc., Ph.D., is a manager on the Oncology team at Clarivate. She has expertise in various solid and hematological malignancies and immune-oncology drug classes, such as immune checkpoint inhibitors and CAR T-cell therapies. As a Ph.D. and postdoctoral fellow at the International Centre for Genetic Engineering and Biotechnology (ICGEB), Dr. Ghosh studied host-pathogen interactions during Mycobacterium tuberculosis and Dengue virus infections. She received her Ph.D. in life sciences from ICGEB and an M.Sc. in biomedical sciences from the University of Delhi.

Login to access report
Back to all Market Assessment reports
Login to access report

launch Related Market Assessment Reports